Background and Aims: Very-early-onset inflammatory bowel disease [VEO-IBD] is a form of IBD that is distinct from that of children with an older onset. We compared changes over time in the incidence and phenotype at diagnosis between two groups according to age at IBD diagnosis: VEO-IBD diagnosed before the age of 6 years, and early-onset IBD [EO-IBD] ]. Crohn's disease ]. Rectal bleeding and mucous stools were more common in patients with VEO-IBD, whereas weight loss and abdominal pain were more frequent in those with EO-IBD. Regarding CD, isolated colonic disease was more common in the VEO-IBD group [39% vs 14%; p = 0.003].
Introduction
Inflammatory bowel diseases [IBDs] , comprising Crohn's disease [CD] and ulcerative colitis [UC] , are multifactorial chronic disorders evolving with a relapsing and remitting course. It is generally accepted that genetic susceptibility, environmental factors, and changes in the gut microbiota cause excessive innate and adaptive immune responses. [1] [2] [3] Paediatric-onset IBD represents 8-25% of cases of IBD. 4, 5 The incidence of paediatric-onset IBD is increasing, especially in industrialised countries, and children are now being diagnosed at a younger age. 6, 7 A small number of monogenic mutations [8] [9] [10] [11] have been identified in children with IBD diagnosis at a very young age, but genome-wide association studies failed to detect large differences between adult-onset and paediatric-onset disease. 12, 13 Several studies reported different disease phenotypes in children with a diagnosis of IBD before 10 years of age compared with children aged over 10 years, 5, 14, 15 adolescents, or adults, leading to the Paris modification of the IBD Montreal classification, differentiating children with a diagnosis made before 10 years of age [A1a] from those with a diagnosis at 10-17 years [A1b]. 16 Thus, age at diagnosis is important clinically and it appears that very-early-onset IBD [VEO-IBD] [age < 6 years at diagnosis] might be a distinct form. The phenotype of children with VEO-IBD is loosely defined but is usually considered as being more severe than when diagnosed later in life. [17] [18] However, most published studies have not been population based but covered patients followed in referral centres, and the incidence and natural history of VEO-IBD are still poorly understood.
In this population-based study covering 1988-2011, we compared changes over time in the incidence and phenotype at diagnosis between VEO-IBD and early-onset [EO]-IBD [diagnosis at 6-16 years].
Patients and Methods

Patient population and EPIMAD methodology
The study population included all children prospectively recorded in the EPIMAD registry with a diagnosis of definite or probable CD, UC, or unclassified inflammatory bowel disease [IBDU] , diagnosed before 17 years of age from January 1988 to December 2011, according to validated and published diagnostic criteria. 5, [18] [19] [20] [21] [22] The study population was divided into two groups according to age at diagnosis; VEO-IBD was defined as IBD diagnosed before 6 years of age, and EO-IBD was defined as IBD diagnosed between 6 and 16 years of age. The cut-off of 6 years was chosen based on previous studies. 7, 14, 15, 17 The EPIMAD Registry is a prospective population-based study recording all cases of IBD documented since 1988 in Northern France [ Figure 1 ]. This study area includes 5 864 508 inhabitants, representing 9.3% of the total French population, and is divided into four administrative areas. The methodology of the EPIMAD Registry has been described in detail. 5, [18] [19] [20] [21] [22] Briefly, data from all patients newly diagnosed with IBD are collected from all adult [N = 254] and paediatric [N = 15] gastroenterologists [GEs] practising in the private and public sectors in these regions of France. Only residents of the studied areas at the time of diagnosis are included. Each GE reports all patients consulting for the first time with clinical symptoms compatible with IBD; he/she is contacted by phone at least three times a year by an interviewer who visits the GE's office and collects data from medical charts on a standardized questionnaire for each new case. The data collected include age at diagnosis, gender, interval between the onset of symptoms and diagnosis, and clinical, radiological, endoscopic and histological findings at the time of diagnosis. Information on the management of each diagnosis is also recorded. The final diagnosis of IBD is established by two expert gastroenterologists and recorded as definite, probable, or possible CD or UC, according to previously published criteria. 20 Only definite and probable cases are considered for further analyses. Cases for which the diagnosis of IBD is probable, but without conclusive argument for differentiating CD from UC, are classified as IBDU.
Approval was obtained from the Ethics Committee of Lille University and Hospital, and this study followed the regulations and instructions set up by the Comité National des Registres [approval numbers 97 107 and 983 792].
Additional data collected for the present study
Data were extracted from the medical records of adult and paediatric GEs, and were collected in standardised questionnaires. [ii] For UC, the location was defined as follows: proctitis defined as involvement limited to the rectum [E1]; left-sided colitis defined as involvement limited to the colorectum below the splenic flexure To assess the evolution of IBD phenotype over time adequately, only patients who had a complete bowel investigation [small and large bowel for CD and total colonoscopy for UC] were considered. The rate of complete bowel investigations did not change over time
Statistical analysis
Incidence rates were computed as the number of incident cases [i.e. new diagnoses] divided by the population at risk. To identify any possible changes in the incidence of IBD, we divided the 24-year study into eight equal 3-year periods: 1988-1990, 1991-1993, 1994-1996, 1997-1999, 2000-2002, 2003-2005, 2006-2008, and 2009-2011] . The mean annual incidence rates were calculated for each 3-year period and for the entire study period, and are presented with their 95% confidence intervals [CIs] . Incidence rates were determined in the overall population and in subgroups according to age categories [< 6 or 6-16 years] and gender. For each of the four administrative areas, population data by age and gender were obtained using yearly estimations of population obtained from INSEE, and based on a mixed procedure exhaustive census before 2004 and random sampling after 2004. Temporal trends in incidences over time were tested by means of log-linear Poisson regression analyses taking overdispersion and person-years at risk into account [introduced as an offset variable after log transformation].
Qualitative variables were expressed as frequencies and percentages and 95% CIs. For comparing qualitative variables between age groups, we used chi-square or Fisher's exact test according to the number of expected events. Analyses were performed with SAS software version 9.4 [SAS Institute Inc., Cary, NC, USA]. Statistical significance was accepted at p ≤ 0.05. A total of 1370 IBD cases were diagnosed between the ages of 6 and 16 years and were considered as EO-IBD; 52% of the patients were male, with no significant difference between the two age groups.
Results
Incidence
In the VEO-IBD group, the incidence of IBD over the entire study period Figure 2 ]. The increasing incidence in the EO-IBD group was noteworthy for cases of EO-UC and EO-CD, whereas the incidences of VEO-UC and VEO-CD remained stable during the study period [ Figure 3 ]. group [40% vs 26%] and CD more common in the EO-IBD group than in the VEO-IBD group [74% vs 60%; Figure 4 ].
IBD classification at diagnosis
IBD phenotype at diagnosis
In cases of CD, isolated colonic disease [L2] was significantly more frequent in the VEO-IBD group [N = 9; 39%] than in the EO-IBD group [N = 128; 14%; p = 0.003; Table 1 UC location at diagnosis was not different between the two age groups [p = 0.138]. Regarding the location at diagnosis in the VEO-CD group or the VEO-UC group, no significant difference was found between children aged 2 years or younger [31% of the VEO-IBD group] and children aged 3-6 years. 
Initial IBD clinical presentation
IBD diagnosis was more often performed in hospital in the VEO-IBD than in the EO-IBD group [69% vs 43%; p < 10 -3 ]. There was no significant difference in the prevalence of a family history of IBD between the two age groups. The time between the onset of symptoms and IBD diagnosis was not influenced by age at diagnosis in our cohort in any type of IBD. The initial clinical presentation was different according to age groups [ Table 1 ].
All IBD patients [N = 1412]
Rectal bleeding and mucous stools were significantly more frequent in the VEO-IBD group than in the EO-IBD group [81% vs 46%; p < 10 -4 and 40% vs 21%; p = 0.002, respectively], whereas weight loss and abdominal pain were less common [21% vs 49%; p < 10 -3 and 43% vs 74%; p < 10 -4 , respectively]. There were no differences in the frequency of diarrhoea or EIMs between the two age groups. Diagnostic procedures [gastroscopy, total colonoscopy, ileoscopy, CT, and MRI scans] were performed as frequently in the VEO-IBD group as in the EO-IBD group.
CD patients [N = 1032]
CD diagnosis was more often performed in hospital in the VEO-CD group than in the EO-CD group [68% vs 45%; p = 0.02]. Only rectal bleeding was significantly more frequent in the VEO-CD group [68% vs 30%; p < 10 -4 ] whereas weight loss and abdominal pain were less common in the VEO-CD group [20% vs 56% and 48% vs 80%, respectively; p < 10 -3 ].
UC patients [N = 343]
UC diagnosis was more often performed in hospital in the VEO-UC group than in the EO-UC group [71% vs 34%; p < 10
]. Only 
Discussion
This population-based prospective study, conducted in a large paediatric cohort [N = 1412] over a 24-year period, showed that the incidence of EO-IBD increased by 116% in Northern France from 1988 to 2011 whereas the incidence of VEO-IBD remained stable during the same period. CD was the most common IBD in the two age groups, with a more frequent isolated colonic location in the VEO-IBD group. UC and IBDU were more common in the VEO-IBD group than in the EO-IBD group. The diagnosis of VEO-IBD was most often performed in hospital. Rectal bleeding and mucous stools were more frequent at diagnosis in the VEO-IBD group, reflecting a colonic location, whereas weight loss and abdominal pain were the most frequent clinical symptoms in the EO-IBD group. Previous epidemiological data have shown a dramatic increase in paediatric-onset IBD worldwide. [23] [24] [25] [26] [27] [28] We also found that the incidence of EO-IBD in our cohort, but not that of VEO-IBD, has been rising continuously since 1988. It is generally accepted that the influence of genetics in the pathogenesis of IBD is higher in children with VEO-IBD. It is unlikely that genetic factors have changed over a period of 24 years, as opposed to environmental factors. This could explain the increased incidence of IBD in those aged 6-16 years and the stability in the incidence of VEO-IBD. 14 showed a proportion of VEO-IBD similar to that in our population, namely 4% and 5%, respectively. This proportion was lower than the 6.5-15% reported previously. This wide range in the prevalence of VEO-IBD is probably associated with the study population, with higher prevalence rates being reported in studies from referral centres. In contrast to the stable incidence of VEO-IBD over time in our study, a Canadian study 14 showed that the increased incidence of IBD from 1994 to 2009 was higher in those with VEO-IBD [< 6 years] [+ 7.4% average yearly change] than in those aged 10-16 years with IBD [+ 2.2% average yearly change].
Our study was performed through a population-based registry, whereas Benchimol et al.
14 applied a diagnosis algorithm through a health administrative database. In addition, our study was focused on a specific region in France, a narrower area than that studied by Benchimol, which might have influenced the results. Therefore, our conclusions should be interpreted with caution.
Although most represented in both age groups, CD was significantly more common in the EO-IBD group than in the VEO-IBD group; UC was significantly more common in the VEO-IBD group than in EO-IBD group in our study. However, CD represented 60% of IBD cases in our VEO-IBD group, unlike previous studies that reported a predominance of UC over CD in VEO-IBD. 14, 15, 29, 32 This could have arisen from the diagnostic criteria used, as well as from specific environmental factors and lifestyle in the study area. 33, 34 Complete bowel investigations were obtained as often in the VEO-IBD group as in the EO-IBD group and the diagnostic criteria [definite or probable IBD cases] did not change over time. Thus, the risk of misdiagnosing patients seems to have been low.
In children with VEO-IBD, the diagnosis was most often done in a hospital setting. This was probably because of the lack of expertise and equipment-particularly endoscopy-for diagnosing IBD in very young children in an extra-hospital environment, as well as higher parental anxiety levels concerning the age of the child, leading parents to consult hospitals. Moreover, the time between the onset of symptoms and diagnosis was not delayed in the VEO-IBD group, whatever the type of IBD. As previously reported, 7, 14, 15, 17, 29, 35 the initial presentation was different according to age group, with mucous bloody stools significantly more frequent in cases of VEO-IBD, probably because of the higher rate of isolated colonic disease in those with CD and a higher proportion of UC compared with older children. As noted by Gupta et al., 17 weight loss and abdominal pain were significantly more common in the EO-IBD group and this was also the case in our study. This was likely linked to a higher proportion of CD in this age group and the difficulties in expressing abdominal pain among very young children. Gupta et al. 17 also reported that the rates of EIMs at diagnosis of IBD were similar in both age groups. In those with CD, the rate of complicated behaviours [B2 or B3] was similar in both age groups in our study, which contrasts with Gupta et al.'s finding of a higher rate of complicated behaviours in those with IBD aged 6-16 years/ 17 Upper gastrointestinal location [L4] and anoperineal lesions were found to be similar in both age groups. The rate of L4 among those with VEO-CD [32%] was similar to that reported by Aloi et al. 15 but much higher than that found by Heyman et al. [5%] . 7 In those with UC, the rates of ulcerative proctitis [E1] and extensive colonic involvement [E3/E4] were similar in both age groups. In the literature, VEO-UC has been studied less than VEO-CD, which currently limits the detection of significant phenotypic differences between the two age groups.
In our study, age at diagnosis of IBD was not linked to the presence of a positive family history, which contrasts with findings from referral centres 7, 32, 36 where it has been shown that severe cases of IBD that are more often followed in referral centres are more often associated with a family history of IBD. 37 The differences between studies could also be explained by the ethnic variability in the study areas. For example, some North American cities included in previous studies have a large Jewish population, in which there is a known genetic susceptibility to IBD. 30 Some recent studies identified novel gene variants associated with all cases of IBD but also in those with VEO-IBD, and sequencing exomes could be a new diagnostic tool to identify variants in genes that could contribute to the pathogenesis of VEO-IBD. [39] [40] [41] [42] Our study had some strengths and limitations. It was a large population-based study, had a long duration, used validated and published diagnostic criteria, and had a high-level data collection [96.5%]. 20 However, because of the small number of patients with VEO-IBD, the results should be interpreted with caution.
In conclusion, our large paediatric-onset population-based study over a 24-year period showed stability in the incidence of VEO-IBD, with a classification into UC and IBDU more frequent than in those aged 6-16 years with IBD. The diagnosis of VEO-IBD was most often done in a hospital setting and the initial presentation with colorectal symptoms was associated with a more frequent isolated colonic involvement in those with CD. Further longitudinal studies, especially genetic, are needed to increase the understanding of the pathogenesis of IBD and to help predict the subsequent course of these rare diseases in very young children and improve treatment strategies. 
